The identified microRNAs and DNA methylation patterns in patients with CTEPH provide further insight into the complex regulatory mechanisms at play, affecting processes from fibrinogen degradation to TGF-β signaling and PASMC migration. The gene discussed is TGFB1; the disease is chronic thromboembolic pulmonary hypertension.